LOADING ...

remdesivir's posts - English uPOST

Mar 26, 2020. 12 comments

Pharma Giant Gilead Retracts Request FDA Extend Monopoly Status on Experimental Covid-19 Drug

Pharma Giant Gilead Retracts Request FDA Extend Monopoly Status on Experimental Covid-19 Drug

Pharmaceutical giant Gilead Sciences on Wednesday retracted its effort to score extended monopoly rights and tax breaks on its antiviral drug remdesivir, which scientists are evaluating as a possible treatment in the novel coronavirus pandemic.

Per the Intercept, on Monday the Food and Drug Administration awarded Gilead “orphan” drug status for remdesivir, which would give it a marketing...

12 Comments

Language